S. Bhagwat

机构：Ambrx (United States), Inhibrx (United States)

发表论文 5 篇 · 总被引 13 次 · h-index 2

代表论文

• Recombinant Alpha-1 Antitrypsin–Fc Fusion Protein INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study (2024 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 被引 10)
• Evaluation of Safety and Pharmacokinetics of the Recombinant Human AAT-Fc Fusion Protein INBRX-101 in Patients with Alpha-1 Antitrypsin Deficiency (2022 · 被引 2)
• Recombinant Human Alpha-1 Antitrypsin (AAT) Protein INBRX-101 Demonstrates Potential to Achieve Lung Penetration and Normal Functional Serum AAT Levels in Patients With AAT Deficiency (2023 · 被引 1)
• PK/PD Characterization of INBRX-140, a Novel anti-FcRn x anti-albumin bispecific antibody (2024)
• INBRX-101: A Novel Recombinant AAT-Fc Fusion Protein That Achieves Normal Serum AAT Levels with Extended Interval Dosing for Patients with Alpha-1 Antitrypsin Deficiency (2022)